A case of bullous pemphigoid in a malignant melanoma patient following an increased Th2/Th1 ratio in peripheral blood cells after nivolumab treatment

Eur J Dermatol. 2023 Oct 1;33(5):550-551. doi: 10.1684/ejd.2023.4571.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Blood Cells / pathology
  • Humans
  • Melanoma* / drug therapy
  • Melanoma* / pathology
  • Nivolumab / adverse effects
  • Pemphigoid, Bullous* / chemically induced
  • Pemphigoid, Bullous* / pathology
  • Skin Neoplasms* / drug therapy
  • Skin Neoplasms* / pathology

Substances

  • Nivolumab